Amygdala Temporal Interference Stimulation for Depression

This clinical trial is focused on exploring a new way to help people with depression by using a special method that stimulates a part of the brain called the right amygdala. This area is known to play a role in emotions and mood regulation. The study aims to see if this targeted brain stimulation can effectively reduce symptoms of depression. Depression is a common condition that can severely impact daily life, so finding new treatments is important to offer more options to those affected. Participants in the study will undergo a brain stimulation procedure, which carefully targets the right amygdala to potentially improve their mood and overall mental health. The study will assess the treatment's effectiveness by monitoring changes in depressive symptoms, cognitive abilities, and how well participants can perform daily activities. Safety is also a key focus, ensuring that the procedure does not pose any significant risks to the participants. By carefully measuring these outcomes, the study aims to provide valuable insights into whether this innovative approach can offer a new avenue for treating depression.